A NEW PATH FOR SCREENING OF BLADDER CANCER
Our researchers, in collaboration with researchers from the University of Tennessee, have taken another small but stubborn step in the fight against cancer by defining a new metabolomic signature for bladder cancer. This opens up new scenarios for understanding the basic mechanisms of neoplastic transformation and for explaining the aggressiveness of some cancers. The results of this study, just published by the journal Applied Science, also indicate an innovative possibility for a population screening system for this disease that affects over 26,000 people a year in Italy alone.
THEOREO SRL AT THE MICROPHONE OF BIOTECHNOLOGY NEWs
Our CEO guest at the microphones of Biotechnology news. A chat about the present and future of biotechnologies in Italy.
OUR CEO TEACHER OF THE OMICS SCIENCE COURSE AT THE UNIVERSITY OF SALERNO
Our CEO has obtained the position of lecturer for the exercise mode of the Omics Science course at the Department of Chemistry and Biology "A. Zambelli" of the University of Salerno. The course is active as part of the degree course in Biology.
OUR CEO TEACHER OF METABOLOMICS AT THE UNIVERSITY OF SANNIO
Our CEO has obtained the position of lecturer for the Metabolomics course at the Department of Science and Technology of the University of Sannio. The course is active within the degree program in Genetic and Molecular Biotechnology.
INTESTINAL MICROBIOTA: A STOP TO THE DEVELOPMENT OF COLON-RECTUM CANCER DISCOVERED
Our spin-off partnered with Humanitas University in a study that demonstrated, for the first time, that a strain of gut bacteria plays a protective role against the development of colorectal cancer. The results of the research, supported by AIRC - AIRC Foundation for Cancer Research and directed and coordinated by Prof. Maria Rescigno of Humanitas University, were recently published in the journal "Nature Microbiology".
This study lays the foundations to put a stop to the development of colorectal cancer that affects more than 34,000 people every year in Italy alone.
CONGRESSO NAZIONALE DELLA SOCIETÀ ITALIANA DI PSICOPATOLOGIA DELL'ALIMENTAZIONE
Il nostro CEO ha tenuto una presentazione su invito al prestigioso congresso nazionale della SIPA (Società Italiana di Psicopatologia dell'Alimentazione) tenutosi a Torino presso l'aula Magna del Rettorato "Cavallerizza Reale" il 23 e 24 maggio. Il tema di quest'anno è stato: "Stress e disturbi dell'alimnetazione: reti neurali, reti sociali, reti terapeutiche".
L'intervento presentato da Theoreo è stato: "La metabolomica nello studio dell'anoressia nervosa: possibilità e limiti"
"Metabolomics and complex systems in molecular diagnostics" Talk At Salerno University
Theoreo is one of the gemma project's partners
The European Commission has selected the GEMMA project which aims at identifying potential targets able to favor personalized treatment and prevention of Autism Spectrum Disorders. The study will have a budget of € 14.2M.
GEMMA is an innovative scientific research project for the evaluation of interactions between microbiome, metabolome, epigenome and immune response in order to provide new diagnostic and preventive approaches to autism.
Metabolomic profiles in the progression of non alcoholic fatty liver disease
Dr. Mario Masarone, researcher at the University of Salerno presented at the annual meeting of the American Association for the Study of Liver Diseases (AASLD), held in San Francisco (CA, USA) in November 2018 the study: "Metabolomic profiles in the progression of non alcoholic fatty liver disease". Theoreo is contributing to this exciting study designed by prof. Marcello Persico, Associate Professor of Internal Medicine of the University of Salerno and Director of the Unit of Internal Medicine and Hepatology of P.O. G. Da Procida - AOU Sand Giovanni di Dio e Ruggi D'Aragona, aims to understand the impact of genes-environment relationships in the progression of hepatic steatosis.
In the "details" the link for access to the interview of dr. Masarone at the InfomedicaEducation microphones
MAMA Test – Presented at the ICBDSR Annual Meeting in Prague
Femal cancers prevention day
Theoreo will be present on 18 May from 16:00 to 20:00 in Salerno on the waterfront "Trieste" in a day for the prevention of female tumors. At that site it will also be possible to participate in the clinical trial for the validation of the MEDEA Test.
medea-test first paper
The MAMA Test will be presented on 23-27 June at the annual meeting of the Teratology Society in Clearwater, Florida. Our CEO Jacopo Troisi is the only Italian to have won the Travel award for this presentation
medea-test first paper
It is on line on the site of the "Journal of Proteome Research" the first paper describing the MEDEA-Test
mama-test first paper (chromosomal anomalies)
It is on line on the site of the "Metabolomics" journal the first paper describing the MAMA-test
metabolomics summer school 2017
Professors Sean Richards and Steve Symes from the University of Tennessee (USA) are visiting our laboratory to do placental metabolomic experiments on intrauterine growth restriction within the "Metabolomic Summer School 2017"
METABOLOMICS AND ENDOMETRIAL CANCER: THEOREO-LILT COLLABORATION
The Italian League for Fight against Cancer (LILT) selected and founded our project "assessment of the efficacy of the metabolomic approach in the screening of endometrial cancer", on which we will work in cooperation with the LILT section in Avellino
mama test clinical validation trial
Now on-line the description of the clinical trial for the validation of the MAMA Test
tHE MEDEA TEST PATENT DESCRIPTION IS NOW AVAILABLE ON LINE
The WIPO (World Intellectual Property Organization) website has just published on-line the description of the Invention on which the MEDEA Test is based.
Theoreo colloborates on the cd-gemm project
Thanks to the partnership with the EBRIS foundation and with the Mass General Hospital for Children of the Harvard University, Theoreo will be “the last M” of the CD-GEMM (Celiac Disease-Genetic Environmental Microbiome and Metabolomic Study) international study, which aims at comprehending the mechanisms of onset of celiac disease.
the mama test patent description is now available on-line
The WIPO (World Intellectual Property Organization) website has just published on-line the description of the invention on which the MAMA test is based.
Progettiamo il futuro con L'Europa
The EBRIS Foundation will host the conference “Progettiamo il futuro con l'Europa”
Theoreo and SuperQuark
Theoreo Srl hosted at its laboratory of metabolomics the shots of a report for the TV programme “SuperQuark”.